Dataset

Clinical Trial Protocol: VAC053 Protocol v5.0

Alternative title:: VAC 053:Safety and immunogenicity of a protein particle malaria vaccine candidate, R21, administered with and without Matrix-M1 in healthy UK volunteers

Documentation:: This is a clinical trial protocol relating to the VAC 053 study, conducted by the Jenner Institute, sponsored by The University of Oxford.

Version:: 5.0

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Hill, A. (2019). Clinical Trial Protocol: VAC053 Protocol v5.0. University of Oxford.

MLA Style

Hill, A. Clinical Trial Protocol: VAC053 Protocol v5.0. University of Oxford, 2019.

Chicago Style

Hill, A. 2019. Clinical Trial Protocol: VAC053 Protocol v5.0. University of Oxford.
Print

Access Document

Files:: VAC053_Protocol_V5.0_Clean_11_07_2016.pdf

(Preview, pdf, 1.8MB, Terms of use)

Authors/Creators

+ Hill, A More by this author/creator

Department:: Nuffield Department of Medicine; Jenner Institute
Role:: Contributor, Adapter, Researcher, Creator

+ European Commission Framework 7 More from this funder

Publisher:: University of Oxford
Publication date:: 2019
Version number:: 5.0
DOI:: 10.5287/bodleian:pdb47Dra9

Pubs id:: 1480131
UUID:: uuid:e4d463f1-9d95-4f6b-a47d-fcb36281f97d
Local pid:: pubs:1480131
Deposit date:: 2019-07-15
ARK identifier:: ark:/29072/ora_e4d463f19d954f6ba47dfcb36281f97d

Terms of use

Copyright date:: 2019

Licence:: ORA Terms and conditions

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP